Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Buy
34
+7
+26% +$2.33K ﹤0.01% 735
2026
Q1
$7.86K Buy
27
+1
+4% +$320 ﹤0.01% 694
2025
Q4
$7.83K Hold
26
﹤0.01% 666
2025
Q3
$7.49K Buy
+26
New +$8.29K ﹤0.01% 677
2023
Q1
Sell
-21
Closed -$3.86K 1048
2022
Q4
$3.86K Sell
21
-52
-71% -$9.53K ﹤0.01% 722
2022
Q3
$13K Buy
73
+15
+26% +$3.21K ﹤0.01% 595
2022
Q2
$12K Buy
+58
New +$13.8K ﹤0.01% 560
2019
Q3
Sell
-1,189
Closed -$334K 318
2019
Q2
$334K Buy
+1,189
New +$311K 0.11% 58

Other funds holding CPAY

Crewe Advisors's CPAY Position: Q2 2026 in Review

Crewe Advisors increased its Corpay (CPAY) stake by 26% in Q2 2026, buying an estimated $2.33K and bringing the position to 34 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Crewe Advisors first reported a position in CPAY in Q2 2019 and has held it in 8 quarters since. The position peaked at $334K in Q2 2019. 727 funds tracked by Wall St. Rank hold CPAY as of Q2 2026.

  • Crewe Advisors held 34 shares of Corpay worth $11.3K as of Q2 2026.
  • Crewe Advisors bought 7 Corpay shares in Q2 2026, an estimated $2.33K.
  • Corpay made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #735 holding.
  • Crewe Advisors first reported a position in Corpay in Q2 2019 and has held it in 8 quarters since.
  • Crewe Advisors's Corpay position peaked at $334K in Q2 2019.
  • 727 funds tracked by Wall St. Rank held Corpay as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.